Pranlukast—The First Orally Active Cysteinyl Leukotriene Receptor Antagonist Marketed for the Treatment of Asthma

Autor:	Jeffrey W. Dubb, Anthony S. Rebuck
Rok vydání:	2016
Předmět:	Orally active business.industry medicine Antagonist Pharmacology medicine.disease business Pranlukast Cysteinyl leukotriene receptor medicine.drug Asthma
DOI:	10.1201/b13993-19
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::cb8405fdd58c926d1e4acec9272503ff https://doi.org/10.1201/b13993-19 Zobrazit plný text záznamu